Global Parkinson Disease Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Parkinson Disease Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Most people with Parkinson"s disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

According to our (Global Info Research) latest study, the global Parkinson Disease Drug market size was valued at US$ 6036 million in 2023 and is forecast to a readjusted size of USD 9045 million by 2030 with a CAGR of 6.0% during review period.

Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.

This report is a detailed and comprehensive analysis for global Parkinson Disease Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Parkinson Disease Drug market size and forecasts, in consumption value ($ Million), 2019-2030

Global Parkinson Disease Drug market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Parkinson Disease Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Parkinson Disease Drug market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Parkinson Disease Drug

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Parkinson Disease Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Parkinson Disease Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Parkinson Disease Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Market segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Market segment by players, this report covers
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Parkinson Disease Drug product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Parkinson Disease Drug, with revenue, gross margin, and global market share of Parkinson Disease Drug from 2019 to 2024.

Chapter 3, the Parkinson Disease Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson Disease Drug market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson Disease Drug.

Chapter 13, to describe Parkinson Disease Drug research findings and conclusion.